DGAP-News: Moderna and ROVI Expand Long-term Collaboration for the Manufacture of MRNA Medicines Over the Next Ten Years

DGAP-News: Moderna, Inc. / Key word(s): Agreement Moderna and ROVI Expand Long-term Collaboration for the Manufacture of MRNA Medicines Over the Next Ten Years 16.02.2022 / 08:35 The issuer is solely responsible for the content of this announcement. MODERNA AND ROVI EXPAND LONG-TERM COLLABORATIO...

Related Keywords

Germany ,United Kingdom ,Madrid ,Spain ,Italy ,Portugal ,Cambridge ,Cambridgeshire ,Henares ,Murcia ,Poland ,France ,Beatriz Garc ,Lavina Talukdar ,Luke Mircea Willats ,Juan Andres ,Laboratorios Farmac ,Marta Campos Mart ,Antonio Marquina Ospina ,Exchange Commission ,Corporate Communications ,Moderna Inc ,Nasdaq ,Distribution Services ,Long Term Collaboration ,Next Ten Years ,San Sebasti ,Chief Technical Operations ,Belmonte Encina ,Chief Executive Officer ,Private Securities Litigation Reform Act ,Annual Report ,Vice President ,Campos Mart ,Corporate News ,Regulatory Announcements ,Long Term ,Collaboration ,Manufacture ,Rna ,Medicines ,Dover ,Text ,Pen ,Tears ,The ,End ,Ovi ,Xpand ,Ollaboratio ,